DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Vanessa Ngan, Staff Writer; Dr Amy Stanway, Registrar, Department of Dermatology, Waikato Hospital, Hamilton, New Zealand, 2002.
Sarcoidosis is a multisystem granulomatous disease. This means there are scattered collections of mixed inflammatory cells (granulomas) affecting many different parts of the body. Characteristically these are non-caseating epithelioid granulomas (a pathological description distinguishing sarcoidal granulomas from the caseating or cheese-like granulomas seen in tuberculosis).
Sarcoidosis usually starts in the lungs or lymph nodes in the chest. It is thought that inflammation of the alveoli (tiny sac like air spaces in lungs where carbon dioxide and oxygen are exchanged) is the start of the disease process in the lungs. This may either clear up on its own or lead to granuloma formation and fibrosis (scarring). Over 90% patients have some type of lung problem. Once considered a rare disease, sarcoidosis is now the most common of the fibrotic lung disorders.
Other commonly affected organs (i.e. outside the lungs) include the following:
Sarcoidosis occurs worldwide, affecting persons of all races, age, and sex.
Not much is known about sarcoidosis and to date there is no known cause or causes. It is thought to be a disorder of the immune system where there is a malfunction in the body's natural defence mechanisms. Whether this abnormal immune response is a cause of sarcoidosis or an effect of the disease still needs to be answered.
Continued research is necessary to answer remaining questions such as:
Sarcoidosis may not result in symptoms and the disease may come and go without the patient or doctor ever being aware of it. Symptoms can appear suddenly and then just as quickly resolve spontaneously. Sometimes, however they can continue over a lifetime.
Symptoms can be related to the specific organ affected, or they can be non-specific general symptoms, including:
Sarcoidosis may involve one organ system or several.
Symptoms and signs of specific organ involvement
|Skin (cutaneous sarcoidosis)||
How is sarcoidosis diagnosed?
There is no single or specific diagnostic test for sarcoidosis. The following tests may be performed when sarcoidosis is suspected.
|Slit-lamp eye examination||
These tests will not only be used to help confirm diagnosis but can also help the doctor to monitor the progress of the disease over time and determine whether the condition is improving or deteriorating.
For most patients with sarcoidosis no treatment is required. Symptoms are usually not disabling and tend to disappear spontaneously. In mild-to-moderate cases, because the disease can resolve on its own spontaneously, a 3 months observation period is recommended before commencing any treatment. When treatment is necessary the aim is to keep the lungs and other affected organs functioning and to relieve symptoms.
In most patients initial treatment is with corticosteroids; these are used to treat inflammation and granuloma formation. Prednisone is the most often prescribed corticosteroid. This may need to be continued for several years as the disease can often relapse once treatment stops.
It is often difficult to know when to start treatment, what drugs and dose to prescribe, and how long to treat for, as the disease can often resolve without any tratment. The decision depends on the organ systems involved and how far the inflammation or granuloma formation has progressed.
Monitoring the disease is essential as treatment can then be modified accordingly.
In general, sarcoidosis appears briefly and resolves without relapse in most cases. 20-30% of patients are left with some permanent lung damage and 10-15% develop chronic sarcoidosis that may last for many years.
In 5-10% of cases the disease can become fatal if either granulomas or fibrosis seriously affects vital organs such as the lungs, heart, nervous system, liver or kidneys. End-stage lung disease may need lung transplantation.
Cutaneous sarcoidosis usually has a prolonged course. Papules and nodules tend to resolve over months or years, whilst plaques may be more resistant. Lupus pernio is often present in patients with chronic fibrotic sarcoidosis and is associated with involvement of the upper respiratory tract, advanced lung fibrosis, bone cysts and eye disease.
With correct diagnosis and proper management, most patients with sarcoidosis continue to lead a normal life.
© 2019 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.